Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum level changes of matrix metalloproteinases 2 and 9, vascular endothelial growth factor and epidermal growth factor receptor during platinum-based chemotherapy in advanced non-small cell lung cancer patients.
Mihaylova Zh, Ludovini V, Gregorg V, Floriani I, Pistola L, Toffaneti F, Ferraldeschi M, Spreafico A, Ceresoli GL, Bellet M, Darwish S, Tonato M, Raynov J. Mihaylova Zh, et al. Among authors: ferraldeschi m. J BUON. 2007 Jan-Mar;12(1):105-11. J BUON. 2007. PMID: 17436410 Clinical Trial.
Effects of gefitinib on serum epidermal growth factor receptor and HER2 in patients with advanced non-small cell lung cancer.
Gregorc V, Ceresoli GL, Floriani I, Spreafico A, Bencardino KB, Ludovini V, Pistola L, Mihaylova Z, Tofanetti FR, Ferraldeschi M, Torri V, Cappuzzo F, Crinò L, Tonato M, Villa E. Gregorc V, et al. Among authors: ferraldeschi m. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6006-12. doi: 10.1158/1078-0432.CCR-03-0770. Clin Cancer Res. 2004. PMID: 15447984
Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluation.
Metro G, Chiari R, Mare M, Giannarelli D, Tofanetti FR, Minotti V, Ferraldeschi M, Giuffrida D, Marcomigni L, Bennati C, Fischer MJ, Meacci M, Bellavita R, Pistola L, Ludovini V, Crinò L. Metro G, et al. Among authors: ferraldeschi m. Cancer Chemother Pharmacol. 2011 Dec;68(6):1405-12. doi: 10.1007/s00280-011-1632-x. Epub 2011 Apr 6. Cancer Chemother Pharmacol. 2011. PMID: 21468755
Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington's Disease: A Pilot Study.
Romano S, Romano C, Peconi M, Fiore A, Bellucci G, Morena E, Troili F, Cipollini V, Annibali V, Giglio S, Mechelli R, Ferraldeschi M, Veneziano L, Mantuano E, Sani G, Vecchione A, Umeton R, Giubilei F, Salvetti M, Corbo RM, Scarabino D, Ristori G. Romano S, et al. Among authors: ferraldeschi m. Int J Mol Sci. 2022 Oct 18;23(20):12440. doi: 10.3390/ijms232012440. Int J Mol Sci. 2022. PMID: 36293304 Free PMC article.
Circulating hsa-miR-323b-3p in Huntington's Disease: A Pilot Study.
Ferraldeschi M, Romano S, Giglio S, Romano C, Morena E, Mechelli R, Annibali V, Ubaldi M, Buscarinu MC, Umeton R, Sani G, Vecchione A, Salvetti M, Ristori G. Ferraldeschi M, et al. Front Neurol. 2021 May 5;12:657973. doi: 10.3389/fneur.2021.657973. eCollection 2021. Front Neurol. 2021. PMID: 34025560 Free PMC article.
Disentangling the molecular mechanisms of multiple sclerosis: The contribution of twin studies.
Buscarinu MC, Fornasiero A, Ferraldeschi M, Romano S, Reniè R, Morena E, Romano C, Pellicciari G, Landi AC, Fagnani C, Salvetti M, Ristori G. Buscarinu MC, et al. Among authors: ferraldeschi m. Neurosci Biobehav Rev. 2020 Apr;111:194-198. doi: 10.1016/j.neubiorev.2020.01.024. Epub 2020 Jan 21. Neurosci Biobehav Rev. 2020. PMID: 31978439 Review.
The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology.
Buscarinu MC, Fornasiero A, Romano S, Ferraldeschi M, Mechelli R, Reniè R, Morena E, Romano C, Pellicciari G, Landi AC, Salvetti M, Ristori G. Buscarinu MC, et al. Among authors: ferraldeschi m. Front Immunol. 2019 Aug 28;10:1916. doi: 10.3389/fimmu.2019.01916. eCollection 2019. Front Immunol. 2019. PMID: 31555257 Free PMC article. Review.
Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority.
Romano S, Ferraldeschi M, Bagnato F, Mechelli R, Morena E, Caldano M, Buscarinu MC, Fornasiero A, Frontoni M, Nociti V, Mirabella M, Mayer F, Bertolotto A, Pozzilli C, Vanacore N, Salvetti M, Ristori G. Romano S, et al. Among authors: ferraldeschi m. Front Neurol. 2019 Jul 16;10:695. doi: 10.3389/fneur.2019.00695. eCollection 2019. Front Neurol. 2019. PMID: 31379701 Free PMC article.
20 results